Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiretroviral Agents”

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT02531295
What this trial is testing

Immunologic Response to Kansui in Treated HIV+ Individuals: a Dose Escalation Study

Who this might be right for
HIVHuman Immunodeficiency Virus
University of California, San Francisco 5
Post-approval studies (Phase 4)Study completedNCT00976040
What this trial is testing

Optimal Time to Start Antiretroviral Therapy in HIV-infected Adults With Cryptococcal Meningitis

Who this might be right for
Cryptococcal MeningitisHIV Infections
Botswana-UPenn Partnership 28
Testing effectiveness (Phase 2)Study completedNCT00071890
What this trial is testing

Phase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Antiretroviral Treatment in HIV-Infected Patients With CD4 T-Lymphocyte Count Greater Than 500 Cells/mm3 Who Received Antiretroviral Tx

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 148
Large-scale testing (Phase 3)Not Yet RecruitingNCT05173324
What this trial is testing

Integration of HPV Vaccination and HPV-based Cervical Screening Into ARV Clinics: the H2VICTORY Trial

Who this might be right for
HPV Infection
International Agency for Research on Cancer 8,000
Large-scale testing (Phase 3)Study completedNCT00450580
What this trial is testing

HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV-1 Infection
ViiV Healthcare 212
Testing effectiveness (Phase 2)WithdrawnNCT00614640
What this trial is testing

Safety and Tolerability of a Therapeutic DNA Dendritic Cell Vaccine in HIV-Infected Children, Adolescents, and Young Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Large-scale testing (Phase 3)Study completedNCT02422797
What this trial is testing

Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-2)

Who this might be right for
HIV Infections
ViiV Healthcare 518
Large-scale testing (Phase 3)Study completedNCT00162682
What this trial is testing

Monitoring Highly Active Antiretroviral Therapy in HIV-infected Parents in Thailand

Who this might be right for
HIV Infections
Institut de Recherche pour le Developpement 716
Not applicableStudy completedNCT01771562
What this trial is testing

Nutritional and Metabolic Disorders in HIV Infected Children and Adolescent

Who this might be right for
HIV-1
ANRS, Emerging Infectious Diseases 330
Testing effectiveness (Phase 2)Active Not RecruitingNCT06411223
What this trial is testing

Pharmacist-led Intervention for Injectable HIV Treatment for Women With Health-related Social Needs

Who this might be right for
Hiv
Yale University 50
Post-approval studies (Phase 4)Ended earlyNCT01367210
What this trial is testing

Switch to Darunavir/r + Maraviroc Quaque Die in Patients With R5 Tropism by Viral DNA Genotyping (GUSTA)

Who this might be right for
HIV Infection
Catholic University of the Sacred Heart 165
Testing effectiveness (Phase 2)Study completedNCT00000820
What this trial is testing

A Phase II Study of Low-Dose Interleukin-2 by Subcutaneous Injection in Combination With Antiretroviral Therapy Versus Antiretroviral Therapy Alone in Patients With HIV-1 Infection and at Least 3 Months Stable Antiretroviral Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 104
Not applicableStudy completedNCT00016588
What this trial is testing

Tenofovir Disoproxil Fumarate (TDF) in HIV-1 Patients Who Have Never Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
Gilead Sciences
Not applicableStudy completedNCT03367130
What this trial is testing

Improving Clinic Attendance for Medication Collection Among HIV Positive Individuals in Nepal

Who this might be right for
HIV InfectionsAntiretroviral TherapyHIV Seropositivity
Tokyo University 468
Post-approval studies (Phase 4)UnknownNCT00120419
What this trial is testing

Mycophenolate Mofetil in Antiretroviral Naïve Patients 2 (MAN2 Study)

Who this might be right for
HIV Infection
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07655128
What this trial is testing

Early Neutralizing Antibodies in Infants Living With HIV to Enhance Their Life

Who this might be right for
HIV -1 Infection
Hospital Universitario 12 de Octubre 87
Testing effectiveness (Phase 2)Study completedNCT00036465
What this trial is testing

Effects of Changing HIV Therapy at Lower Versus Higher Viral Loads

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 60
Early research (Phase 1)Study completedNCT00129194
What this trial is testing

Study of KP-1461 for the Treatment of HIV Positive Patients Who Have Failed Multiple HAART Regimens

Who this might be right for
HIV Infections
Koronis Pharmaceuticals. 40
Not applicableStudy completedNCT00009256
What this trial is testing

Analysis of HIV Genetic Variation in Patients Before Beginning Highly Active Antiretroviral Therapy

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 65
Not applicableStudy completedNCT03187964
What this trial is testing

Xpert Ultra and Xpert HIV-VL in People Living With HIV

Who this might be right for
HIV/AIDSTB - TuberculosisAntiretroviral Therapy, Highly Active
University of Stellenbosch 1,053
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation